| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |